Rani Therapeutics GAAP EPS of -$0.22, revenue of $0.17M
Source: SeekingAlpha
2025-05-14 11:05:22 ET
More on Rani Therapeutics
- Rani Therapeutics Holdings, Inc. (RANI) Q4 2024 Earnings Call Transcript
- Rani Therapeutics Holdings, Inc. 2024 Q4 - Results - Earnings Call Presentation
- Seeking Alpha’s Quant Rating on Rani Therapeutics
- Historical earnings data for Rani Therapeutics
- Financial information for Rani Therapeutics
Read the full article on Seeking Alpha
For further details see:
Rani Therapeutics GAAP EPS of -$0.22, revenue of $0.17M
Rani Therapeutics Holdings Inc.
NASDAQ: RANI
RANI Trading
-17.13% G/L:
$0.9116 Last:
1,798,892 Volume:
$1.05 Open:
RANI Latest News
March 26, 2026 04:05:00 pm
Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update
March 25, 2026 04:53:16 pm
Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization
March 19, 2026 04:05:00 pm
Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results
January 28, 2026 07:00:00 am
Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer
RANI Stock Data
$162,838,596
86,413,825
3.84%
30
N/A
Biotechnology & Life Sciences
Healthcare
US
San Jose
